Profiel
Ami Shah Brown is currently a Senior Vice President-Regulatory Affairs at Icosavax, Inc. Prior to this, she worked as a Senior Vice President-Regulatory Affairs at Inovio Pharmaceuticals, Inc. from 2011 to 2022.
She also worked as an Assistant Professor at George Washington University.
Dr. Brown received her undergraduate degree from the University of Pennsylvania, her graduate degree from Emory University, and her doctorate from Johns Hopkins Bloomberg School of Public Health.
Actieve functies van Ami Shah Brown
| Bedrijven | Functie | Begin |
|---|---|---|
| ICOSAVAX, INC. | General Counsel | - |
Eerdere bekende functies van Ami Shah Brown
| Bedrijven | Functie | Einde |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | General Counsel | 01-03-2022 |
| George Washington University | Corporate Officer/Principal | - |
Opleiding van Ami Shah Brown
| University of Pennsylvania | Undergraduate Degree |
| Emory University | Graduate Degree |
| Johns Hopkins Bloomberg School of Public Health | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
